OEF Returned 314.83% Over Years, SPY Trailed Over Ten Years
Over the last decade, the iShares S&P 100 ETF led large-cap funds with outsized gains, but 2026’s early volatility hi...
Overview of a yearly tax planning approach for index fund losses, detailing steps to track opportunities, document losses, and optimize filings.
19,656 articlesOver the last decade, the iShares S&P 100 ETF led large-cap funds with outsized gains, but 2026’s early volatility hi...
Archer’s Q1 2026 numbers set the tone for the year. This article breaks down the earnings call, explains what really ...
Lucid Diagnostics (LUCD) is navigating reimbursement and adoption as it scales its non-invasive tests. This analysis ...
Friday Reads offers a disciplined way to close the week. This investing digest blends macro themes, private market pe...
Take a practical tour of arcutis (arqt) 2026 earnings, from revenue mix and margins to pipeline progress and risk fac...
When public battles heat up, your wallet can feel the heat too. This article breaks down how political noise affects ...
Howard Lindzon explains that seed investing hinges on a power-law mindset: most bets fail, but one or two extraordina...
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
BlackRock unveils the iShares Bitcoin Premium Income ETF, BITA, a yield-focused crypto product using an active covere...
A family emergency can attract scammers. This guide explains how impersonator lawyers operate, the real-cost risks, a...
A prominent market observer says Strategy may have to liquidate more than 50,000 BTC by 2028 to cover obligations, si...
Structure Therapeutics stock 187% gains over the last year drew attention from value seekers and momentum players ali...